Show pageBacklinksCite current pageExport to PDFBack to top This page is read only. You can view the source, but not change it. Ask your administrator if you think this is wrong. Ipatasertib is an experimental cancer drug in development by Roche. It is a small molecule inhibitor of [[AKT]], which is a key component of the [[PI3K/AKT/mTOR pathway]]. It was discovered by Array Biopharma and is currently in phase II trials for treatment of breast cancer. ipatasertib.txt Last modified: 2024/06/07 02:57by 127.0.0.1